share_log

Virpax Pharmaceuticals | 8-K: Current report

Virpax Pharmaceuticals | 8-K: Current report

Virpax制药 | 8-K:重大事件
美股sec公告 ·  07/26 16:34
Moomoo AI 已提取核心信息
Virpax Pharmaceuticals, Inc., a Delaware-incorporated company, has announced the full prepayment of its senior secured promissory note on July 25, 2024. The note, which was issued to an investor on July 5, 2024, had a maturity date of December 31, 2025, and was secured by a lien on all of the company's assets. The total payment made by Virpax Pharmaceuticals included both the principal and accrued interest, amounting to approximately $2,525,000. The note carried an interest rate of 18% per annum. This financial move was disclosed in a Form 8-K report filed with the United States Securities and Exchange Commission. The company, listed on The Nasdaq Capital Market under the trading symbol VRPX, is also classified as an emerging growth company.
Virpax Pharmaceuticals, Inc., a Delaware-incorporated company, has announced the full prepayment of its senior secured promissory note on July 25, 2024. The note, which was issued to an investor on July 5, 2024, had a maturity date of December 31, 2025, and was secured by a lien on all of the company's assets. The total payment made by Virpax Pharmaceuticals included both the principal and accrued interest, amounting to approximately $2,525,000. The note carried an interest rate of 18% per annum. This financial move was disclosed in a Form 8-K report filed with the United States Securities and Exchange Commission. The company, listed on The Nasdaq Capital Market under the trading symbol VRPX, is also classified as an emerging growth company.
Virpax Pharmaceuticals公司是一家注册于特拉华州的公司,在2024年7月25日宣布已全额偿付其于2024年7月5日向投资者发行的高级担保本票,该本票的到期日为2025年12月31日,并以公司的所有资产作抵押。Virpax Pharmaceuticals所支付的总金额包括本金和应计利息,共计约252.5万美元。该本票的年利率为18%。该项财务举措已在提交给美国证券交易委员会的8-K表格中披露。该公司以交易代号VRPX在纳斯达克资本市场上市,也归类为新兴成长型公司。
Virpax Pharmaceuticals公司是一家注册于特拉华州的公司,在2024年7月25日宣布已全额偿付其于2024年7月5日向投资者发行的高级担保本票,该本票的到期日为2025年12月31日,并以公司的所有资产作抵押。Virpax Pharmaceuticals所支付的总金额包括本金和应计利息,共计约252.5万美元。该本票的年利率为18%。该项财务举措已在提交给美国证券交易委员会的8-K表格中披露。该公司以交易代号VRPX在纳斯达克资本市场上市,也归类为新兴成长型公司。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息